Project factsheets

Learn more about the projects supported by IHI as well as the Innovative Medicines Initiative (IMI).

IHI/IMI2/IMI1

Status

Call

Programmes

Disease areas

Products

Tools and resources to improve drug development

Clear all filters

Displaying 12 projects/programmes

ADAPT-SMART

Accelerated development of appropriate patient therapies: a sustainable, multi-stakeholder approach from research to treatment-outcomes

GETREAL

Incorporating real-life clinical data into drug development

Closed IMI1 Clinical trial design Real-world data, evidence Regulatory and HTA processes

GetReal Initiative

The GetReal Initiative

Closed IMI2 Clinical trial design Real-world data, evidence Regulatory and HTA processes

PARADIGM

Patients active in research and dialogues for an improved generation of medicines: advancing meaningful patient engagement in the life cycle of medicines for better health outcomes

Closed IMI2 Clinical trial design Patient involvement in R&D Regulatory and HTA processes

PREFER

Patient Preferences in benefit risk assessments during the drug life cycle

Closed IMI2 Clinical trial design Patient involvement in R&D Real-world data, evidence Regulatory and HTA processes Methods for benefit/risk assessment

PREMIER

Prioritisation and risk evaluation of medicines in the environment

Ongoing IMI2 Real-world data, evidence Regulatory and HTA processes Environmental aspects

RESCEU

Respiratory syncytial virus consortium in Europe

Closed IMI2 Respiratory diseases Infectious diseases Biobanks Regulatory and HTA processes

SISAQOL-IMI

Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials

Ongoing IMI2 Cancer Clinical trial design Patient involvement in R&D Regulatory and HTA processes

Trials@Home

Center of excellence – remote decentralised clinical trials

Ongoing IMI2 Clinical trial design Digital health Real-world data, evidence Regulatory and HTA processes

VAC2VAC

Vaccine lot to vaccine lot comparison by consistency testing

Closed IMI2 Infectious diseases Vaccines 3Rs - animal use in research Regulatory and HTA processes

WEB-RADR

Recognising Adverse Drug Reactions

Closed IMI1 Tools for predicting/monitoring efficacy Digital health Regulatory and HTA processes

WEB-RADR 2

Closed IMI2 Tools for predicting/monitoring safety Big data and knowledge management Real-world data, evidence Regulatory and HTA processes Methods for benefit/risk assessment